CD4 and neoplasm: Our studies of the protective efficacy of vaccination in mice challenged twice with B16-OVA tumor cells showed that suppression of challenged tumor growth was attributable to the increased infiltration of both CD4(+) and CD8(+) T lymphocytes into the tumor tissues.